Home » Sign up for our e-Newsletter

Sign up for our e-Newsletter

January 2019 Question of the Month

Are there more challenges with the new lower priced Repatha NDC compared with the higher priced NDC?

Yes: 57.1%

No: 42.9%

Do you think brand manufacturer’s strategy to introduce a lower priced brand NDC of an existing product is going to expand in 2019?

Yes: 85.7%

No: 14.3%

Will there be a(n) ______ number of pharmaceutical product price changes in 2019 compared to 2018?

Increased: 63.64%

Decreased: 0.00%

Similar: 36.36%

Do you believe there are sufficient treatment options for HIV to warrant formulary exclusions?

Yes: 75%

No: 25%

Do you believe there are sufficient treatment options for Hemophilia to warrant formulary exclusions?

Yes: 71%

No: 29%

Do you believe there are sufficient treatment options for Hereditary Angioedema to warrant formulary exclusions?

Yes: 17%

No: 83%